Clinical Trial Update: Pharmacogenetic and Pharmacokinetic Study of Clopidogrel

View source ↗

Summary

A completed trial evaluating how genetic factors and pharmacokinetics influence clopidogrel in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Artery Disease | Status: COMPLETED